Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06617702 · ClinicalTrials.gov registry record · NA

Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial

A NA study of Alcohol Consumption, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT06617702: Recruiting NA study of Alcohol Consumption, sponsored by Stanford University.

NCT06617702 is a NA study of Alcohol Consumption that is actively recruiting participants, run by Stanford University. The registered enrollment target is 300 participants, below the 359-participant average among 18 other Alcohol Consumption trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06617702, a NA study of Alcohol Consumption, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

This project aims to test the efficacy of a text message intervention, ASPIRE, designed to address cognitive and behavioral elements and modify exposure to peers that influence drinking behaviors. Young adults who are contemplating reducing their drinking will be recruited from a national sample and randomized to ASPIRE versus a text message intervention focused solely on cognitive and behavioral elements. We will measure effectiveness at 3, 6, and 12 months, study mechanisms driving behavior change, and identify which subgroups stand to benefit most.

Primary Outcome

We define BDD as a day when a woman reports 4 or more standard drinks or a man reports 5 or more standard drinks, as this equates to the alcohol consumption that raises blood alcohol concentration to 0.08 g/dl or above.

Conditions Studied

Interventions

  • BEHAVIORAL A text message alcohol intervention focused on cognitive, behavioral, and peer influences
  • BEHAVIORAL A text message alcohol intervention focused on cognitive and behavioral influences

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-04-07
Est. Completion 2027-05-31
Phase NA
Stanford University

1,744 total trials

What NCT06617702 shows while recruiting

NCT06617702 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 359-participant average among 18 other Alcohol Consumption trials with a reported enrollment target (16% lower).

The record links to 1 condition, with Alcohol Consumption appearing as the primary indexed condition, and to 2 interventions - of which A text message alcohol intervention focused on cognitive, behavioral, and peer influences is the first listed.

NCT06617702 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06617702 about?

NCT06617702 is a clinical study titled "Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial". This project aims to test the efficacy of a text message intervention, ASPIRE, designed to address cognitive and behavioral elements and modify exposure to peers that influence drinking behaviors. Young adults who are contemplating reducing their drinking will be recruited from a national sample and...

What is the current status of trial NCT06617702?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-04-07. Estimated completion is 2027-05-31.

What conditions does trial NCT06617702 study?

This clinical trial studies the following conditions: Alcohol Consumption.

What interventions are being tested in trial NCT06617702?

The interventions under investigation include: A text message alcohol intervention focused on cognitive, behavioral, and peer influences (BEHAVIORAL), A text message alcohol intervention focused on cognitive and behavioral influences (BEHAVIORAL).

Who is sponsoring clinical trial NCT06617702?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06617702 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Consumption

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06617702's enrollment target sits among peer trials

300 7th of 18 higher than 12 of 18 other Alcohol Consumption trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Consumption trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06617702, the US trial registry maintained by the National Library of Medicine. NCT06617702 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.